XML 33 R12.htm IDEA: XBRL DOCUMENT v3.25.2
MARKETABLE SECURITIES
6 Months Ended
Jun. 30, 2025
MARKETABLE SECURITIES  
MARKETABLE SECURITIES

5. MARKETABLE SECURITIES:

Amortized cost and estimated fair market value of marketable securities classified as available-for-sale (excluding cash equivalents) at June 30, 2025, were as follows:

Amortized

Gross Unrealized

Estimated Fair

(In thousands)

    

Cost

    

Gains

    

Losses

    

Market Value

Investments due in 3 months or less:

 

  

 

  

 

  

 

  

Corporate securities

$

15,661

$

7

$

(10)

$

15,658

Total

 

15,661

 

7

 

(10)

 

15,658

Investments due in 4-12 months:

 

  

 

  

 

  

 

  

Corporate securities

25,976

94

(6)

26,064

Total

 

25,976

 

94

 

(6)

 

26,064

Investments due in 12 months or greater:

 

  

 

  

 

  

 

  

Corporate securities

 

158,421

 

1,663

 

(5)

 

160,079

Total

158,421

 

1,663

(5)

 

160,079

Total marketable securities

$

200,058

$

1,764

$

(21)

$

201,801

Accrued interest receivable was $2.5 million at June 30, 2025 and was recorded within prepaid expenses and other current assets on the condensed consolidated balance sheet.

Amortized cost and estimated fair market value of marketable securities classified as available-for-sale (excluding cash equivalents) at December 31, 2024, were as follows:

Amortized

Gross Unrealized

Estimated Fair

(In thousands)

    

Cost

    

Gains

    

Losses

    

Market Value

Investments due in 3 months or less:

 

  

 

  

 

  

 

  

Corporate securities

$

10,972

$

4

$

(3)

$

10,973

Total

 

10,972

 

4

 

(3)

 

10,973

Investments due in 4-12 months:

 

  

 

  

 

  

 

  

Corporate securities

 

87,346

 

159

 

(19)

 

87,486

Total

 

87,346

 

159

 

(19)

 

87,486

Investments due in 12 months or greater:

 

  

 

  

 

  

 

  

Corporate securities

149,817

 

860

 

(113)

 

150,564

Total

 

149,817

 

860

 

(113)

 

150,564

Total marketable securities

$

248,135

$

1,023

$

(135)

$

249,023

Accrued interest receivable was $2.8 million at December 31, 2024 and was recorded within prepaid expenses and other current assets on the condensed consolidated balance sheet.

The following table summarizes marketable securities classified as available-for-sale (excluding cash equivalents) in a continuous unrealized loss position for which an allowance for credit losses was not recorded at June 30, 2025:

Less Than 12 Months

12 Months or Longer

Total

    

Estimated

    

Gross

    

Estimated

    

Gross

    

Estimated

    

Gross

Fair Market

Unrealized

Fair Market

Unrealized

Fair Market

Unrealized

(In thousands)

Value

Losses

Value

Losses

Value

Losses

Corporate securities

$

9,205

$

(17)

$

2,925

$

(4)

$

12,130

$

(21)

Total marketable securities

$

9,205

$

(17)

$

2,925

$

(4)

$

12,130

$

(21)

In the three and six months ended June 30, 2025 and 2024, no unrealized losses on marketable securities were recognized in income.

The Company does not intend to sell and it is unlikely that it will be required to sell the securities held prior to their anticipated recovery. The issuers are high quality (investment grade) and the decline in fair value is largely due to changes in interest rates. Additionally, the issuers continue to make timely interest payments on the marketable securities with the fair value expected to recover as they reach maturity.